Soul food health trends

Food For Health, Wisconsin's First Medically Tailored Meal Provider Hosts Launch Event

Retrieved on: 
Friday, May 19, 2023
Type 2 diabetes, Obesity, Food, Diabetes, Education, Cardiovascular disease, Food and Health Bureau, Type, Movement, Hypertension, MTM, HQ, Cooking, Immersion, Soul food health trends, FFH, Health, FIMC, Pharmaceutical industry

MILWAUKEE, May 18, 2023 /PRNewswire/ -- This week nearly 200 community leaders, members, and partners attended Food For Health's (FFH) launch event as an independent 501c3 at the organization's new HQ campus located in the Halyard Park Neighborhood. FFH President and CEO Kathy Koshgarian announced a five-year campaign to improve the health of 50,000 lives focusing on Wisconsin's underserved communities. "As Americans, we're spending trillions on health care -- but people are getting sicker -- largely due to preventable diet-related diseases. Here in Wisconsin, up to one-third of our residents have diabetes and spend twice as much on healthcare as a person without," said Koshgarian. "Our FFH medically tailored meal (MTM) program reduces healthcare consumption and costs while managing and reversing diet-related diseases such as Type 2 diabetes, hypertension, obesity, and cardiovascular disease. While food is clearly the problem, it is also the solution. The time to act is now and as we like to say, it's time for a food fight!"

Key Points: 
  • "As Americans, we're spending trillions on health care -- but people are getting sicker -- largely due to preventable diet-related diseases.
  • Here in Wisconsin, up to one-third of our residents have diabetes and spend twice as much on healthcare as a person without," said Koshgarian.
  • "Our FFH medically tailored meal (MTM) program reduces healthcare consumption and costs while managing and reversing diet-related diseases such as Type 2 diabetes, hypertension, obesity, and cardiovascular disease.
  • The time to act is now and as we like to say, it's time for a food fight!"

One in Two Patients Tested Misuse Prescription Drugs, Finds 10th Annual Quest Diagnostics Health Trends® Report

Retrieved on: 
Monday, December 12, 2022
Drug, Benzodiazepine, Soul food health trends, Physician, DGX, Cocaine, Substance-related disorder, Bias, Female, Drug overdose, Fentanyl, Public health, Health, Patient, Quest Diagnostics, Population Health Management, Cancer, Illegal drug trade, Privacy, Hospital, Therapeutic drug monitoring, NYSE, Diabetes, Asthma, Policy, DTI, Allergy, Lyme disease, COVID-19, Roger Hawkins (drummer), Death, Multimedia, Degenerative disease, Safety, Hepatitis, Database, CDC, Amphetamine, Male, Risk, Pharmaceutical industry, Medical device, Dietary supplement

SECAUCUS, N.J., Dec. 12, 2022 /PRNewswire/ -- Today, Quest Diagnostics (NYSE: DGX) released its latest Health Trends® report, "Drug Misuse in America 2022: A Decade Lost to the Drug Crisis." The report, which harnesses insights from more than 20 million clinical drug tests over 10 years, shows that while progress has been made in the last decade of drug misuse, patients of all ages and both sexes are still at risk.

Key Points: 
  • To access the Health Trends report, visit Quest Diagnostics Newsroom - Health Trends .
  • In 2021, nearly half (49%) of people tested showed evidence of prescription drug misuse, compared to 60% in 2012.
  • "This year's Quest Diagnostics Health Trends Report underscores the deeply entrenched pattern of prescription drug misuse," said report co-author Harvey W. Kaufman, M.D., Senior Medical Director and Head of the Health Trends Research Program for Quest Diagnostics.
  • Quest Diagnostics Health Trends is a series of scientific reports that provide insights into health issues, based on patient laboratory data, to empower better patient care, population health management and public health policy.

Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds

Retrieved on: 
Tuesday, October 11, 2022
JCO, Physician, Lung, Quest Diagnostics, Allergy, Informatics, Soul food health trends, DGX, Risk, American Association for Cancer Research, Breast, JCO Clinical Cancer Informatics, Drug, NYSE, ASCO, Society, Patient, Degenerative disease, Hospital, Hepatitis, Asthma, Research, Multimedia, American Society of Clinical Oncology, Cancer, Institute of Cancer Research, Medical Affairs Bureau, Prostate, AACR, MD, American Association, Association, Breast cancer, View, Health, Diabetes, Prostate cancer, DTI, Population Health Management, Adult, Journal, Sexual abuse, Database, Travel, Lyme disease, COVID-19, American Journal of Clinical Oncology, Public health, Medical imaging, Pharmaceutical industry, Animal

SECAUCUS, N.J., Oct. 11, 2022 /PRNewswire/ -- More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nation's leading causes of cancer death, continue to lag behind pre-pandemic levels, according to a nationally representative Quest Diagnostics Health Trends® study by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.

Key Points: 
  • While cancer diagnoses increased over the subsequent two years, the gains have not been enough to offset diagnoses delayed or missed earlier in the pandemic.
  • Diagnoses of prostate and breast cancer remained significantly below pre-pandemic levels as late as period 3, at 17% and 11% respectively.
  • "As an oncologist, I am particularly disturbed by the finding that cancer diagnoses for breast and prostate cancer are well below pre-pandemic levels.
  • Breast and prostate cancer are expected to account for nearly 30% of new cancer diagnoses in 2022.

Quest Diagnostics Aims to Close Gaps in Maternal Healthcare with New Obstetrics Test Panel that Includes Hepatitis C Screening

Retrieved on: 
Wednesday, August 17, 2022
Reflex, Hepatitis C, Multimedia, Public health, Sexual abuse, Prevalence, NYSE, Asthma, Degenerative disease, Society for Maternal-Fetal Medicine, Syphilis, CBC, Database, Pregnancy, Hospital, Health, Lyme disease, Patient, CDC, Medicaid, Society, HBV, Rubella, Soul food health trends, Drug, Women's health, Gynaecology, Hepatitis B, Medicine, Obstetrics and gynaecology, Population Health Management, American College of Obstetricians and Gynecologists, Quest Diagnostics, Physician, Diabetes, United States Preventive Services Task Force, HIV, DGX, Solution, HCV, MD, DTI, Adult, Allergy, Medical device, Medical imaging, Vaccine, Pharmaceutical industry, Obstetrics

SECAUCUS, N.J., Aug. 17, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people easily and reliably for hepatitis C (HCV) with other laboratory tests typically ordered during early pregnancy.

Key Points: 
  • "Our Health Trends research revealed that despite guidelines recommending HCV screening in pregnancy, many people are not receiving the testing they need.
  • Individuals in underserved communities are most likely to experience this gap in care," said Damian "Pat" Alagia, MD, Senior Medical Director, Women's Health, Quest Diagnostics.
  • The reports are based on the Quest Diagnostics database of 60 billion deidentified laboratory test results, believed to be the largest of its kind in healthcare.
  • iii ACOG Practice Advisory: Routine Hepatitis C Virus Screening in Pregnant Individuals (opqic.org) Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB.

Survey of Human Resource Executives and Office Workers Suggests Employee Health May be a Key Ingredient to Addressing the "Great Resignation"

Retrieved on: 
Monday, May 9, 2022
COVID-19, Thought, Population, Senior, Work, HRE, Degenerative disease, NYSE, Physician, HR, Organization, Soul food health trends, Cancer, Diabetes, Hospital, Conditional sentence, Database, Adult, R, Health, Wal-Mart: The High Cost of Low Price, Medicine, View, Mental health, Research, Multimedia, DGX, Health insurance, Management, Medical imaging, Quest Diagnostics

SECAUCUS, N.J., May 9, 2022 /PRNewswire/ -- As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy may be a key ingredient to keeping employees well and at work. Among employees thinking about changing jobs, better benefits in general (38%), better healthcare benefits specifically (36%), as well as work/life balance (36%), were three of the top four reasons employees were considering the change. More money was the top reason, at 50%.

Key Points: 
  • Among the findings: Two-thirds of employees (66%) say they are thinking about changing jobs next year or have begun or recently completed a job change.
  • Among the key findings, there was strong agreement--87% of HREs and 89% of employees--that health insurance is too expensive, and that the pandemic's effects on health will drive costs even higher.
  • Costs loom large for a substantial majority of HREs, who appreciate the financial burden of healthcare costs borne by employees.
  • Early detection and treatment of many chronic illnesses, including cancer, diabetes and heart disease, is associated with improved health outcomes.

Over Half of U.S. Children Have Detectable Levels of Lead in their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics

Retrieved on: 
Tuesday, September 28, 2021
Department of Neurology, Xuanwu hospital, Blood, Paint, Medicaid, Boston Children's Hospital, Population, White, Common Good, Adoption detective, JAMA Pediatrics, Editorial, BLL, MPH, Hearing, Learning, District, Harvard Medical School, DGX, Associate Director of National Intelligence and Chief Information Officer, CDC, Boston College, Lead, NYSE, Gasoline, The Journal of Pediatrics, Environmental Health (journal), Harvard T.H. Chan School of Public Health, Lead poisoning, Pediatrics, Poisoning, FAAP, Risk, Brain, Doctor of Philosophy, Department, Environmental Protection Administration, Parent, Hospital, Master of Science, Environment, Public health, URL, Nebraska, Soul food health trends, Poverty, Medical device, Pharmaceutical industry, Medicine, Dietary supplement, Jet fuel

With this study, Quest Diagnostics seeks to bolster incomplete national data on childhood lead exposure and investigate the individual- and community-level factors associated with blood lead levels (BLLs) in children.

Key Points: 
  • With this study, Quest Diagnostics seeks to bolster incomplete national data on childhood lead exposure and investigate the individual- and community-level factors associated with blood lead levels (BLLs) in children.
  • Still, the new Quest analysis reveals that the majority of American children have been exposed to lead, despite decades of public policies to reduce lead poisoning.
  • "Our Quest analysis finds that while exposure to the highest levels of lead has declined in recent years, most American children are exposed to lead, a substance that is not safe for children at any level.
  • Low Level Lead Exposure 355 Harms Children : A Renewed Call for Primary Prevention Advisory Committee on 356 Childhood Lead Poisoning Prevention.

Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open

Retrieved on: 
Tuesday, August 31, 2021
Cancer, Degenerative disease, Drug, Diagnosis, Gaps, Diabetes, Database, Physician, Prostate, Research, Lyme disease, Travel, Disease, Population Health Management, Sexual abuse, List of American Medical Association journals, Allergy, Asthma, Fear, Hospital, NYSE, DTI, JAMA Network Open, Health, Public health, Multimedia, Pandemic, Adult, Patient, Soul food health trends, White Americans, Lung, Breast, DGX, COVID-19, Medical imaging, Pharmaceutical industry

It builds on research the Quest team published in August 2020 in JAMA Network Open that found a 46.4% decline in newly diagnosed cases of six cancers from March 1 to April 18, 2020.

Key Points: 
  • It builds on research the Quest team published in August 2020 in JAMA Network Open that found a 46.4% decline in newly diagnosed cases of six cancers from March 1 to April 18, 2020.
  • Cancer may not cause symptoms in early stages, and patients may be unaware that they have the disease without evaluation and testing.
  • The investigators examined the mean monthly number of cancer diagnoses versus the pre-pandemic period to provide averages per period.
  • Quest Diagnostics Health Trends is a series of scientific reports that provide insights into health topics, based on analysis of objective clinical laboratory data, to empower better patient care, population health management and public health policy.

Gluten Free Food Market to hit $15 Billion by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, November 21, 2019
Diets, Articles, Health, Food and drink, Gluten-free diet, Gluten, Healthy diet, Gluten-free beer, Soul food health trends

SELBYVILLE, Delaware, Nov. 21, 2019 /PRNewswire/ -- Global Gluten Free Food Market is projected to cross USD 15 billion by 2026, according to a new research report by Global Market Insights, Inc.

Key Points: 
  • SELBYVILLE, Delaware, Nov. 21, 2019 /PRNewswire/ -- Global Gluten Free Food Market is projected to cross USD 15 billion by 2026, according to a new research report by Global Market Insights, Inc.
  • Changing outlook towards low cholesterol and fat free alternatives, and rising awareness towards healthy diets may boost gluten free food demand.
  • Some major findings of the gluten free food market statistics report include:
    Increasing prevalence of digestive disorders in Europe market may trigger the demand for light and gluten free alternatives.
  • Asia Pacific gluten free food market share may increase owing to rising disposable income and increasing consumer propensity to spend on healthy food choices.

Gluten Free Food Market to hit $15 Billion by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, November 21, 2019
Diets, Articles, Health, Food and drink, Gluten-free diet, Gluten, Healthy diet, Gluten-free beer, Soul food health trends

SELBYVILLE, Delaware, Nov. 21, 2019 /PRNewswire/ -- Global Gluten Free Food Market is projected to cross USD 15 billion by 2026, according to a new research report by Global Market Insights, Inc.

Key Points: 
  • SELBYVILLE, Delaware, Nov. 21, 2019 /PRNewswire/ -- Global Gluten Free Food Market is projected to cross USD 15 billion by 2026, according to a new research report by Global Market Insights, Inc.
  • Changing outlook towards low cholesterol and fat free alternatives, and rising awareness towards healthy diets may boost gluten free food demand.
  • Some major findings of the gluten free food market statistics report include:
    Increasing prevalence of digestive disorders in Europe market may trigger the demand for light and gluten free alternatives.
  • Asia Pacific gluten free food market share may increase owing to rising disposable income and increasing consumer propensity to spend on healthy food choices.